Doxazosin Tablet
Product Images NDC 71335-2786

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Doxazosin (NDC 71335-2786). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (Image 1)

FDA Label Image

Image (Image 2)

This is not-available*

FDA Label Image

1 (Image 3)

This text provides information on the mean change in total symptom score and the mean increase in maximum urinary flow rate from baseline during a treatment study. It includes a graph showing the duration of treatment in weeks and the corresponding changes in symptoms and flow rate. The results suggest a significant improvement in symptom score compared to placebo and baseline, as well as a doxazosin titration up to a maximum of 8 mg.*

FDA Label Image

Label (Lbl713352786)

This text is from a package insert of Doxazosin Mesylate tablets containing 4 mg of Doxazosin as a free base. It also mentions the recommended dosage, storage instructions, and manufacturer information. The insert advises to keep the medication in a well-closed container and out of reach of children. Additionally, it suggests scanning the package's QR code for prescribing information.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.